A 12-week pranayama and relaxation program nearly halved the number of headache days experienced by people with chronic migraine compared with standard care alone, according to a randomized controlled trial published in Complementary Therapies in Medicine. The intervention group saw an average drop of 7.1 headache days per month, against 4.6 days in the medication-only control group.
For people who live with 15 or more headache days per month, the headline threshold for chronic migraine, that gap is the difference between losing a week to pain and reclaiming most of it. The findings add weight to a growing body of evidence that yoga and breathwork belong inside a multidisciplinary migraine plan, not at the margins of it.
What The Trial Tested
The study randomized 90 adults with chronic migraine into two arms. One group received daily guided sessions of pranayama and relaxation (the P+R arm) alongside their usual pharmacological care. The control arm continued with medication alone, no behavioural component added.
The pranayama and relaxation protocol was delivered for 12 weeks. Sessions were guided rather than self-directed, which the authors note made the dose easier to standardise across participants. Researchers tracked three primary clinical outcomes: monthly headache frequency, pain intensity during attacks, and disability scores, the last of which captures how much migraine interfered with daily life and work.
They also took a less common second look at the data, measuring autonomic nervous system markers, the silent background system that controls heart rate, blood pressure, and the body’s switch between stress and rest.
What The Trial Found
The clinical numbers point in one direction. Across all three primary endpoints, the pranayama and relaxation group outperformed standard care alone:
- Headache frequency: a mean reduction of 7.1 days per month in the P+R arm versus 4.6 days in the control arm.
- Pain intensity: a significantly greater drop in self-reported pain during attacks.
- Disability: meaningfully larger reductions in disability and quality-of-life scores.
The autonomic findings are where the trial got physiologically interesting. Participants in the P+R arm showed increased parasympathetic activity, lower resting blood pressure, and lower resting heart rate. In plain terms, the breath and relaxation work appeared to shift the nervous system out of a chronically activated state, the same kind of state that other recent breathwork RCTs have also targeted.
No adverse events were reported. Adherence to the daily protocol was high, which the authors describe as supportive of feasibility outside a research setting.
Why The Autonomic Result Matters
Migraine is increasingly being understood not just as a vascular or neurological event but as a condition with strong autonomic involvement. People with chronic migraine often live in low-grade sympathetic dominance, the fight-or-flight side of the nervous system. Heart rate variability is often blunted. Sleep is fragile. Stress reactivity is high.
Pranayama and relaxation practices work on this terrain directly. Slow nasal breathing, extended exhalations, and conscious relaxation engage the vagus nerve and shift the balance toward the parasympathetic branch. The trial’s autonomic measurements suggest the headache reduction was not happening in isolation, it was paired with a measurable change in the physiology that surrounds migraine.
That distinction is part of why mind-body interventions in chronic pain are now being framed as adjunctive medicine rather than alternative medicine. The trial authors explicitly describe the protocol as an “adjunctive therapy”, a complement to pharmacological care, not a replacement.
What This Means For You
If you have chronic migraine, the practical takeaway from the trial is not “switch off your medications”. The control group also received standard care, and the gains were on top of it. The takeaway is that a daily breath-and-relaxation routine, sustained for at least 12 weeks, was associated with meaningful clinical change that medication alone did not deliver.
A few things worth noting before starting any practice:
- Daily and guided beats occasional and self-directed. The trial used guided daily sessions. Sporadic 10-minute YouTube sessions are not what was studied.
- Twelve weeks is the floor. Most of the clinical change in mind-body trials shows up between weeks 8 and 12. Short trials often miss the signal.
- Slow over forceful. The autonomic gains came from calming practices, not high-intensity breathwork. Holotropic-style or rapid breathing can trigger migraines in sensitive individuals.
- Coordinate with your clinician. If you take preventives or use abortive medications, keep your team in the loop. The trial protocol was layered onto medical care, not run in isolation.
Three Practices Worth Trying
The trial’s protocol combined pranayama with relaxation, which lines up with three accessible practices that have appeared in other autonomic studies and in traditional migraine yoga therapy.
1. Nadi Shodhana (Alternate-Nostril Breathing)
A balancing practice that slows the breath while keeping the body alert. Practitioners report a settling effect on the head and sinuses, and it is one of the most studied pranayama techniques in autonomic research. A clear walkthrough of the technique is laid out in our nadi shodhana and bhramari guide.
2. Bhramari (Humming-Bee Breath)
The vibration of the exhalation appears to stimulate the vagus nerve and is widely recommended in Indian clinical yoga protocols for chronic headache. It is also one of the easier pranayamas to learn without a teacher, which matters for adherence.
3. Guided Body-Scan Relaxation
The “relaxation” half of the protocol is often glossed over but does most of the parasympathetic heavy lifting. A 15- to 20-minute supine relaxation, with progressive attention to face, jaw, shoulders, and chest, is the structural cousin of yoga nidra and is well tolerated by people with active migraine, who often cannot sit comfortably during an attack.
How This Trial Fits A Bigger Pattern
The chronic migraine result does not stand alone. A growing string of randomized trials in 2025 and 2026 has shown clinical benefit from yoga and breathwork in conditions that share the same physiological backbone as migraine, namely a stressed and dysregulated autonomic system.
- A 2026 network meta-analysis found yoga matched aerobic exercise for fibromyalgia, with stronger gains in sleep and mood. See our coverage of the fibromyalgia analysis.
- A 2026 meta-analysis of yoga for chronic low back pain showed it beat conventional exercise on functional outcomes.
- The largest yoga nidra meta-analysis ever published this year confirmed reductions in stress, anxiety, and depression across 73 studies.
Migraine joins that list. The clinical literature is moving away from asking “does yoga help” and toward asking “what dose, for how long, in which population, and through what mechanism”.
Key Takeaways
- A 90-person randomized controlled trial found that 12 weeks of daily pranayama and relaxation reduced chronic migraine days by 7.1 per month, versus 4.6 days in the medication-only control group.
- The intervention also lowered pain intensity, disability scores, resting blood pressure, and resting heart rate, while raising parasympathetic activity.
- The protocol was added to standard care, not used in its place. Authors describe the approach as an adjunctive therapy.
- Adherence was high and no adverse events were reported, suggesting the protocol is feasible outside a research setting.
- Practical takeaway: daily, slow, guided breathwork and supine relaxation, sustained for at least 12 weeks, is the format most aligned with the trial’s findings.
Source: Yoga-based breathing and relaxation as adjunctive therapy for chronic migraine: A randomized controlled trial on clinical outcomes and autonomic regulation, published in Complementary Therapies in Medicine, December 2025.
